Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_assertion type Assertion NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_head.
- NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_assertion description "[The authors analyzed: (1) 25 pretreated surgically resected paraffin-embedded primary adenocarcinomas of the prostate for the presence of EGR-1 expression and mutation, and correlated this with clinical endpoints such as serum prostate-specific antigen levels and current clinical status; (2) 27 postirradiated biopsies of prostate for the presence of EGR-1 expression, and correlated these findings to the residual tumor status; and (3) 12 prospective prostate tumor specimens for EGR-1 expression and its target genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_provenance.
- NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_assertion evidence source_evidence_literature NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_provenance.
- NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_assertion SIO_000772 11586104 NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_provenance.
- NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_assertion wasDerivedFrom befree-2016 NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_provenance.
- NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_assertion wasGeneratedBy ECO_0000203 NP331958.RAUOg9f8pcOr2fpJKZzaPsNQ0z0tN2fbWb6lgAesesgF4130_provenance.